Institutional investors purchased a net $1.1 million shares of IMMU during the quarter ended March 2018, and now own 71.91% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 3.2 Million shares of Immunomedics Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.0 Million shares of Immunomedics Inc